The selling is routine portfolio diversification following option exercises, not a bearish signal. Monitor for any 8-K filings or clinical trial updates that could explain the timing, but the dollar amount is too small to warrant action. The strong historical positive drift on DNTH (70% win rate at T+20) suggests the stock's momentum is intact.
Price Chart
Executive Summary
A cluster of insider selling at Dianthus Therapeutics (DNTH) totaling $2.99M over a 7-day window, led by the CEO ($1.12M) and General Counsel ($1.78M). The selling is concentrated at prices near $107-$111, representing ~0.05% of the $6.1B market cap, which is below the 0.1% materiality threshold. While C-suite participation adds weight, the absolute dollar amount is trivial relative to market cap, and the selling is likely liquidity-driven following option exercises rather than a bearish signal. The historical calibration shows strong positive drift on DNTH (avg T+20 alpha +3.19%), but this cluster is too small to override that trend.
Key Financial Metrics
Key Facts
- Total insider selling of $2.99M over 7 days, representing ~0.05% of $6.1B market cap
- CEO Marino Garcia sold $1.12M (10.4K shares at $107.49) on 2026-08-07
- General Counsel Adam Veness sold $1.78M (16.2K shares at $110.38) on 2026-08-10
- All sales are open-market; several insiders also exercised options at low strike prices ($0-$19.36) on same day
- No insider buying in the cluster; net direction is entirely selling
Financial Impact
$2.99M in open-market sales, ~0.05% of market cap — immaterial
Risk Factors
- CEO selling $1.12M could be misinterpreted as a negative signal by the market
- Cluster selling may accelerate if stock continues to rise, creating overhead supply
- No insider buying to offset the selling pattern
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-DNTH-1786526069166 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Insider Cluster | $112.41 $103.28 | ▼ −8.12% | ▼ −6.22% | $89.96 (−19.97%) |
Aug 11, 2026 7w ago | Insider Cluster | $112.41 $103.28 | ▼ −8.12% | ▼ −6.22% | $89.96 (−19.97%) |
Aug 11, 2026 7w ago | Insider Cluster | $112.41 $103.28 | ▼ −8.12% | ▼ −6.22% | $89.96 (−19.97%) |
Aug 11, 2026 7w ago | Insider Cluster | $112.41 $103.28 | ▲ +8.12% | ▲ +6.22% | $89.96 (+19.97%) |
Aug 10, 2026 7w ago | 144 | $108.49 $107.04 | ▼ −1.34% | ▼ −0.28% | $89.96 (−17.08%) |
Jun 29, 2026 13w ago | Press Release | $95.68 $103.87 | ▲ +8.56% | ▲ +8.84% | $89.96 (−5.98%) |
Jun 12, 2026 16w ago | 8-K | $82.07 $97.60 | ▲ +18.92% | ▲ +17.14% | $89.96 (+9.61%) |
Jun 11, 2026 16w ago | Institutional Cluster | $76.45 $100.03 | ▲ +30.84% | ▲ +28.95% | $89.96 (+17.67%) |
May 5, 2026 21w ago | 8-K | $90.42 $84.97 | ▼ −6.03% | ▼ −8.81% | $89.96 (−0.51%) |
Mar 12, 2026 29w ago | Press Release | $77.86 $90.00 | ▲ +15.59% | ▲ +12.00% | $89.96 (+15.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access